BCAB Competitors & Alternatives
Compare Bioatla Inc with similar stocks in the same industry
Biotechnology
BCAB
Main Stock$1.74
Tradestie Score
39
Market Cap
$39.57M
Revenue Growth
0.3%
Analyst Upside
+476.4%
Top Competitors
237 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$23.99
|
$154.27M | - | 44 | Compare |
|
CCCC
C4 Therapeutics, Inc.
|
$3.51
|
$153.02M | - | 50 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$14.25
|
$133.50M | - | 41 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$6.20
|
$114.01M | - | 44 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$32.00
|
$110.20M | - | 48 | Compare |
|
IRD
Opus Genetics, Inc. Common Stock
|
$6.04
|
$107.83M | - | 38 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.69
|
$97.42M | - | 49 | Compare |
|
ALXO
ALX Oncology Holdings Inc. Common Stock
|
$1.94
|
$96.93M | - | 54 | Compare |
|
ARTV
Artiva Biotherapeutics, Inc. Common Stock
|
$10.22
|
$71.32M | - | 43 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$12.14
|
$67.94M | - | 42 | Compare |
More BCAB Analysis
Data updated: Sep 12, 2026 | Industry: Biotechnology (SIC 2836)
237 stocks in this industry